Synthesis and bioactivity studies of covalent inhibitors derived from (-)-Chaetominine

Xian Zhou,Xuexin Feng,Dachi Wang,Deheng Chen,Gaoxing Wu,Ziqin Yan,Xilin Lyu,Huan Wang,Jin-Ming Yang,Yujun Zhao
DOI: https://doi.org/10.1016/j.molstruc.2021.130694
IF: 3.841
2021-10-01
Journal of Molecular Structure
Abstract:<p>We reported herein the synthesis and bioactivity studies of compounds derived from the natural product (-)-Chaetominine (<strong>6</strong>). The key feature of these compounds is the incorporation of electrophilic groups that are capable of forming covalent bonds with the cysteine or threonine residues of cellular proteins. The cell growth inhibition activities of these derivatives of <strong>6</strong> were tested in four cancer cell lines, i.e. a leukemia cell line K562, a multiple myeloma cell line MM1.S, an acute myeloid leukemia cell line MV4-11, and a colon cancer cell line RKO. The data show that cellular growth inhibition IC<sub>50</sub> values of <strong>29</strong>, an acrylamide-containing molecule, are 9-17 folds more potent than that of <strong>6</strong>, while other acrylamide-containing compounds are much less potent, suggesting <strong>29</strong> might have covalent interactions with cellular target proteins. Collectively, incorporation of an acrylamide moiety into <strong>6</strong> is a good strategy to improve its cell growth inhibition activity in cancer cell lines.</p>
chemistry, physical
What problem does this paper attempt to address?